SCHEMBL7739018

SCHEMBL7739018

CC(=O)Nc1oc(-c2ccc(-c3cccc([N+](=O)[O-])c3)cc2O)nc1-c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.62
FLT1 P17948 1/20 0.62
FLT4 P35916 1/20 0.62
HPN P05981 1/20 0.49
ABCG2 Q9UNQ0 2/20 0.46
ABCB1 P08183 1/20 0.46
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
NQO2 P16083 1/20 0.42
HDAC2 Q92769 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ELANE P08246 1/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
ALOX12 P18054 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744063 0.93 KDR (0.54) KDRFLT1FLT4HPNABCG2
SCHEMBL7744049 0.91 KDR (0.52) KDRFLT1FLT4HPNABCG2
SCHEMBL7744641 0.91 KDR (0.55) KDRFLT1FLT4HPNABCG2
SCHEMBL7739065 0.90 KDR (0.50) KDRFLT1FLT4HPNABCG2
SCHEMBL7746611 0.90 KDR (0.50) KDRFLT1FLT4HPNABCG2
SCHEMBL7744175 0.90 KDR (0.49) KDRFLT1FLT4HPNABCG2
SCHEMBL7746563 0.89 HDAC2 (0.53) KDRFLT1FLT4HPNABCG2
SCHEMBL7744646 0.89 KDR (0.56) KDRFLT1FLT4HPNABCB1
SCHEMBL7744663 0.88 KDR (0.76) KDRFLT1FLT4ALDH1A1MAPT
SCHEMBL7739019 0.87 KDR (0.64) KDRFLT1FLT4HPNABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed